These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20812421)

  • 1. Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries.
    D'Amico AV; Goldhaber SZ
    Harv Heart Lett; 2010 Jul; 20(11):8. PubMed ID: 20812421
    [No Abstract]   [Full Text] [Related]  

  • 2. Ranolazine (Ranexa) in the treatment of chronic stable angina.
    Aslam S; Gray D
    Adv Ther; 2010 Apr; 27(4):193-201. PubMed ID: 20449698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative changes of testosterone and prostate-specific antigen at low and high densities of PSA in men with prostate cancer].
    Khuskivadze AA; Kochiashvili DK
    Georgian Med News; 2007 Feb; (143):67-9. PubMed ID: 17404444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
    Zhang XZ; Donovan MP; Williams BT; Mohler JL
    Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine (ranexa) for chronic angina.
    Med Lett Drugs Ther; 2006 Jun; 48(1236):46-7. PubMed ID: 16770296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ranolazine--new treatment of chronic stable angina pectoris].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Dec; 171(50):3705-7. PubMed ID: 20003868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On call. I've had my PSA tested every year since 1992 and I'm happy to say it's always been normal. But now my doctor doesn't want to do the test anymore because I'm 78 years old. Should I go to another doctor for my test?
    Simon HB
    Harv Mens Health Watch; 2000 Dec; 5(5):8. PubMed ID: 11114879
    [No Abstract]   [Full Text] [Related]  

  • 9. [LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis].
    Pfitzenmaier J; Altwein JE
    Aktuelle Urol; 2009 Mar; 40(2):100-8. PubMed ID: 19253209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer.
    Leewansangtong S; Soontrapa S
    J Med Assoc Thai; 2003 Sep; 86(9):809-15. PubMed ID: 14649965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic stable angina pectoris.
    Rodríguez-Ospina L; Montano-Soto L
    Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
    Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
    Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era.
    Bianco FJ
    Urol Oncol; 2008; 26(4):408-14. PubMed ID: 18593619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer].
    Gleave M; Santo N; Rennie PS; Goldenberg SL; Bruchovsky N; Sullivan LD
    Prog Urol; 1996 Jun; 6(3):375-85. PubMed ID: 8763692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy].
    Peyromaure M; Rebillard X; Ruffion A; Salomon L; Villers A; Soulie M;
    Prog Urol; 2008 Jan; 18(1):2-8. PubMed ID: 18342148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranolazine: a new option in the management of chronic stable angina.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On call. My 64-year-old wife was recently diagnosed with osteoporosis. Her doctor said medication would help, and he reassured her that having osteoporosis was not all bad since it indicates a reduced risk for breast cancer. I want to know if osteoporosis in men affects the risk of prostate cancer.
    Simon HB
    Harv Mens Health Watch; 2010 Jul; 14(12):7-8. PubMed ID: 20795283
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
    Grande M; Carlström K; Rozell BL; Stege R; Pousette A
    Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.